Aabid Hussain

Dr. Aabid Hussain

Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2015 in The Brazilian Journal of Infectious Diseases
Verified
Journal Article
Open access
DMDebarati Mukherjee
Debarati Mukherjee
CSChingakham Brajakishor Singh
Chingakham Brajakishor Singh
SDSomaditya Dey
Somaditya Dey
SMSupratim Mandal
Supratim Mandal
JGJoydip Ghosh
Joydip Ghosh
CPChiranjib Pal
Chiranjib Pal
In the present context of emergence of resistance aligned with the conventional anti-leishmanial drugs and occasional treatment failure compelled us to continue the search for replaceable therapeutic leads against Leishmania infection. Various ginger spices of the Zingiberaceae family are widely used as spices, flavouring agents, and medicines in Southeast Asia because of their unique flavour as well as due to their medicinal properties. Zerumbone, a natural component of Zingiber zerumbet (L.) Smith, has been studied for its pharmacological potential as antiulcer, antioxidant, anticancer, and antimicrobial. In this study, we have shown that zerumbone could induce ROS mediated apoptosis in Leishmania donovani promastigotes and also found effective in reducing intracellular amastigotes in infected-macrophages. We emphasized the potential of zerumbone to be employed in the development of new therapeutic drugs against L. donovani infection and provided the basis for future research on the application of transitional medicinal plants.

9 December 2020 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
DMDebarati Mukherjee
Debarati Mukherjee
YOYousuf
Yousuf
SDSomaditya Dey
Somaditya Dey
SCSondipon Chakraborty
Sondipon Chakraborty
ACAnkur Chaudhuri
Ankur Chaudhuri
CPChiranjib Pal
Chiranjib Pal

20 May 2020 in Infection and Immunity
Verified
Journal Article
Closed access
PDF file
SDSomaditya Dey
Somaditya Dey
DMDebarati Mukherjee
Debarati Mukherjee
SSSirin Salma Sultana
Sirin Salma Sultana
SMSuvadip Mallick
Suvadip Mallick
ADAritri Dutta
Aritri Dutta
CPChiranjib Pal
Chiranjib Pal
The major issues in available therapeutic modalities against leishmaniasis are cost, toxicity, and the emergence of drug resistance. The aim of this work was to develop a successful therapeutic adjuvant against drug-resistant Leishmania donovani infection by means of combining Mycobacterium indicus pranii with heat-induced promastigotes (HIP). One-month postinfected BALB/c mice were administered subcutaneously with M. indicus pranii (10 8 cells) and HIP (100 μg) for 5 days.

1 March 2021 in Fitoterapia
Verified
Journal Article
Open access
CCCarolyne Chepkirui
Carolyne Chepkirui
POPurity J. Ochieng
Purity J. Ochieng
BSBiswajyoti Sarkar
Biswajyoti Sarkar
AHAabid Hussain
Aabid Hussain
CPChiranjib Pal
Chiranjib Pal
AYAbiy Yenesew
Abiy Yenesew
Five known compounds (1-5) were isolated from the extract of Mundulea sericea leaves. Similar investigation of the roots of this plant afforded an additional three known compounds (6-8). The structures were elucidated using NMR spectroscopic and mass spectrometric analyses. The absolute configuration of 1 was established using ECD spectroscopy. In an antiplasmodial activity assay, compound 1 showed good activity with an IC50 of 2.0 μM against chloroquine-resistant W2, and 6.6 μM against the chloroquine-sensitive 3D7 strains of Plasmodium falciparum. Some of the compounds were also tested for antileishmanial activity. Dehydrolupinifolinol (2) and sericetin (5) were active against drug-sensitive Leishmania donovani (MHOM/IN/83/AG83) with IC50 values of 9.0 and 5.0 μM, respectively. In a cytotoxicity assay, lupinifolin (3) showed significant activity on BEAS-2B (IC50 4.9 μM) and HePG2 (IC50 10.8 μM) human cell lines. All the other compounds showed low cytotoxicity (IC50 > 30 μM) against human lung adenocarcinoma cells (A549), human liver cancer cells (HepG2), lung/bronchus cells (epithelial virus transformed) (BEAS-2B) and immortal human hepatocytes (LO2).

18 January 2021 in Natural Product Research
Verified
Journal Article
Closed access
MAMoses Andima
Moses Andima
ANAlbert Ndakala
Albert Ndakala
SDSolomon Derese
Solomon Derese
SBSarkar Biswajyoti
Sarkar Biswajyoti
AHAabid Hussain
Aabid Hussain
AYAbiy Yenesew
Abiy Yenesew
In this study, the antileishmanial and cytotoxic activities of secondary metabolites isolated from Tabernaemontana ventricosa Hochst. ex A. DC., Aloe tororoana Reynolds, and Aloe schweinfurthii var. labworana Reynolds were investigated. Overall, nineteen known compounds were isolated from the three plant species. The compounds were characterized based on their spectroscopic data. Voacristine and aloenin were the most active compounds against promastigotes of antimony-sensitive Leishmania donovani (IC50 11 ± 5.2 μM and 26 ± 6.5 µM, respectively) with low toxicity against RAW264.7, murine monocyte/macrophage-like cells. The in silico docking evaluation and in vitro NO generation assay also substantially support the antileishmanial effects of these compounds. In a cytotoxicity assay against cancer and normal cell lines, ursolic acid highly inhibited proliferation of lung cancer cells, A549 (IC50 6.61 ± 0.7 μM) while voacristine was moderately active against human liver cancer cells, HepG2 (IC50 23.0 ± 0.0 μM). All other compounds were inactive against the test parasites and cell lines.

1 March 2026 in Nanotechnology, Science and Applications
Verified
Journal Article
Open access
PDF file
ARAnupam Singha Roy
Anupam Singha Roy
NBNeelesh Babu
Neelesh Babu
AHAabid Hussain
Aabid Hussain
The discovery of graphene, which has led to further research on other two-dimensional (2D) materials, has greatly enhanced the development of sustainable novel materials in the age of nanotechnology. The majority of elements in the periodic table are currently converted into 2D forms by researchers. Materials such as graphene and its derivatives, transition-metal dichalcogenides (TMDs), and transition-metal carbides (MXenes) have been extensively used because of their exceptional electronic and optical properties. While addressing synthesis challenges and stability issues, functionalization is one of the strategies used to overcome the difficulties related to the stability and large dimensions of 2D materials. This review provides detailed studies on MXene synthesis methods and their characteristic properties, emphasizing the importance of modifying MXenes for biosensing applications such as the detection of pathogenic viruses and bacteria, mycotoxins, hazardous pollutants, food contaminants, biomolecules, and cancer biomarkers. A review of the function of MXenes in hydrogen production highlights how well they improve charge transfer and lower reaction overpotentials. The future prospects of MXene-based biosensors as advanced diagnostic tools and hydrogen catalysts are also discussed, in addition to surface functionalization engineering and hybridization techniques.